about
Intermittent versus continuous androgen suppression for prostatic cancerIntermittent versus continuous androgen suppression for prostatic cancerEnhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactomeMolecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancerSox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancerProstate cancer stem cellsSuppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamideEffects of Brassicaceae Isothiocyanates on Prostate CancerCurrent opinion on the role of testosterone in the development of prostate cancer: a dynamic modelTime for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimenEffect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivoHedgehog Proteins Consume Steroidal CYP17A1 Antagonists: Potential Therapeutic Significance in Advanced Prostate CancerCardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphateEffect of parenteral oestrogen on the coagulation system in patients with prostatic carcinomaGSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cellsEffects of long-term treatment with the anti-androgen bicalutamide on human testis: an ultrastructural and morphometric studyTransversal European survey on testosterone deficiency diagnosis.Mutation of the androgen receptor causes oncogenic transformation of the prostateThe role of GATA2 in lethal prostate cancer aggressiveness.Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancer.Hormonal and Chemotherapeutic Systemic Therapy for Metastatic Prostate Cancer.Redefining hormone resistance in prostate cancer.Use of androgen deprivation therapy for metastatic prostate cancer in older men.Research on reproductive medicine in the pharmaceutical industry.Therapy-associated effects in the prostate gland.Role of transforming growth factor-beta1 in prostate cancer.Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells.Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2.Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer.Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.SEOM clinical guidelines for the treatment of metastatic prostate cancerThe effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy study.Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate.The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma.Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice.Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells.Risk stratification in the hormonal treatment of patients with prostate cancerQuantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.Can Subepididymal Orchiectomy Re-emerge as the Treatment of Choice in Patients with Advanced Prostatic Carcinoma?
P2860
Q24243575-AABA4E8D-8454-491B-9D43-D3711813DDD9Q24246469-4B73E362-4F79-4939-9EB7-851066D5518DQ24294625-DC377846-2883-4D38-9828-0A0F89C1E8D6Q24300845-2418704F-8CB6-4C4B-9120-6D28059DACC6Q24633279-C0B7FD79-65BB-4592-A91A-1D131C82F2C1Q24654712-F5526863-38A2-4CB8-970B-41CA5FA25039Q24669875-CA38B8CB-F3D7-4BBC-8B64-FE043A2C841EQ26749086-35BC4C89-BAB1-4DBA-BDAE-B32BEC6B5A4AQ26778886-8F4F018D-6ED3-4F58-BDC7-5D775889F70FQ28138375-C097A175-8136-46DA-BF9A-EA2BB230220AQ28268982-E78B0ABF-A274-42AC-B077-92821F464F84Q28277254-51B7C01F-BBBC-4976-A3F6-2F4DDD7C316BQ28293003-8F42AFDE-36F3-4E97-902B-7B8C9CFE2962Q28299242-4FF43301-F6FC-4748-85D6-B8A0C365FEB7Q28477278-D55C85F9-A425-4C1E-816B-062E8DF3E881Q29398504-960529D2-925C-4BD3-A0B4-1C624D25095EQ30318156-4E83AB27-40A2-4D5D-9DE1-889C43AC5EE0Q33732154-7BF077F7-24AE-4B95-9FC3-2DA65EF2A544Q33848134-644FF732-2DCB-4526-A86B-206B21B93868Q33853729-5DD3B98D-8D00-41E1-9470-377CDE464C63Q33891545-2EF10BC7-4B85-40D9-B1B5-CE45B87EDB3DQ33903836-02F7CDE6-F7DB-4F67-9043-BA7B3D5E0AF5Q33977514-28810A2F-3A30-4E05-A080-9D2F33C053E2Q34114028-5B9CE0FB-AFAE-4088-966A-A6CE7F1DEC4BQ34115527-D8862FB1-0185-4BA6-9921-DE171AF1AC87Q34136505-33387244-2F97-4252-8208-B917545CB371Q34162761-F038888E-0CD5-4A35-AB6B-04627E99F247Q34278855-34877B68-111B-47A8-8026-DE39DAFBE3C8Q34419367-3ED69B8D-BCBE-4338-906C-05DF25442D25Q34433798-8E9665AA-0641-4641-8DF8-2D34B622E321Q34553405-3EC9DA67-E2BA-4E0F-8B23-60583CFA004EQ34559834-810E2AA4-5723-452F-989A-6FB0AB7A8996Q34563140-466BC8C4-8C51-48E0-A4BE-88ED25940099Q34747431-2143AB2B-4A5E-4FAD-92E6-C8F32A5B71E6Q34789929-09D542E9-94A2-4692-BF9A-12E8B10F6AB4Q34978001-8C56731C-FAC0-4B75-A0BD-7342721EC37FQ34982106-31D60DE4-E9A4-4490-8A22-22071C3C549BQ35076189-CA5B5AE8-850A-4671-A47B-D735D3D39D49Q35202889-D2B810EB-7370-4D39-BC4F-8704EF329917Q35225157-B6655911-A838-48BF-814D-569D2E2D8E52
P2860
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 1941
@uk
name
STUDIES ON PROSTATIC CANCER
@en
STUDIES ON PROSTATIC CANCER
@nl
type
label
STUDIES ON PROSTATIC CANCER
@en
STUDIES ON PROSTATIC CANCER
@nl
prefLabel
STUDIES ON PROSTATIC CANCER
@en
STUDIES ON PROSTATIC CANCER
@nl
P1476
STUDIES ON PROSTATIC CANCER
@en
P2093
CHARLES HUGGINS
P356
10.1001/ARCHSURG.1941.01210140043004
P577
1941-08-01T00:00:00Z